Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide

Key Points

• Mobilization of hematopoietic stem cells improved significantly for gene therapy applications.
• Key evidence includes a notable increase in mobilized stem cells and treatment efficacy.
• This analysis focused on the effects of motixafortide on stem cell mobilization.
• Enhanced mobilization can lead to better gene therapy outcomes for hemoglobinopathies.